A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
A Multicenter, Double-Blind, Placebo Controlled, Phase Ⅱa clinical trial to enroll 120
patients with Vertigo Caused By Posterior Circulation Infarction during 7 days, then to
evaluate the efficacy of different dose of Levophencynonate Hydrochloric, and provide the
effective dosage for phase IIb clinical study, to study the safety of Levophencynonate
Hydrochloric.